ImmuneBiotech

ImmuneBiotech AB is an innovative microbiome research company, discovering and developing novel therapeutics based on probiotics, immunobiotics and synbiotic formulations targeting the microbiome. The company has a pre-clinical stage pipeline of therapeutic lactobacilli combinations for the treatments of chronic inflammatory and infectious diseases.